SB Therapy: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SB Therapy
Largest movements
- Cash +€130,108
up €130,108 (+44.8%), from €290,414 to €420,522
mainly Net result for the year (+€129,248) and Other debts (+€14,862)
- Receivables within one year +€18,799
new in 2025: €18,799
- Profit (loss) carried forward +€129,248
up €129,248 (+45.1%), from €286,474 to €415,722
- Other debts +€14,862
up €14,862 (+4,575%), from €325 to €15,187
- Taxes +€4,711
up €4,711 (+11.3%), from €41,589 to €46,300
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €296,529 | €444,361 | +€147,833 | +49.9% |
| Fixed assets | 21/28 | €5,148 | €3,869 | -€1,279 | -24.8% |
| Tangible fixed assets | 22/27 | €5,148 | €3,869 | -€1,279 | -24.8% |
| Plant, machinery and equipment | 23 | €2,106 | €1,628 | -€478 | -22.7% |
| Furniture and vehicles | 24 | €3,041 | €2,241 | -€800 | -26.3% |
| Current assets | 29/58 | €291,381 | €440,492 | +€149,111 | +51.2% |
| Amounts receivable within one year | 40/41 | - | €18,799 | +€18,799 | |
| Trade receivables | 40 | - | €18,799 | +€18,799 | |
| Cash at bank and in hand | 54/58 | €290,414 | €420,522 | +€130,108 | +44.8% |
| Deferred charges and accrued income | 490/1 | €967 | €1,171 | +€204 | +21.1% |
| Total equity and liabilities | 10/49 | €296,529 | €444,361 | +€147,833 | +49.9% |
| Equity | 10/15 | €294,474 | €423,722 | +€129,248 | +43.9% |
| Contributions | 10/11 | €8,000 | €8,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €286,474 | €415,722 | +€129,248 | +45.1% |
| Amounts payable | 17/49 | €2,055 | €20,640 | +€18,585 | +904% |
| Amounts payable within one year | 42/48 | €2,055 | €20,640 | +€18,585 | +904% |
| Trade debts | 44 | €1,141 | €1,153 | +€12 | +1.1% |
| Suppliers | 440/4 | €1,141 | €1,153 | +€12 | +1.1% |
| Taxes, remuneration and social security | 45 | €589 | €4,300 | +€3,711 | +630% |
| Taxes | 450/3 | €589 | €4,300 | +€3,711 | +630% |
| Other amounts payable | 47/48 | €325 | €15,187 | +€14,862 | +4,575% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,863 | €2,328 | +€464 | +24.9% |
| Other operating charges | 640/8 | €387 | €807 | +€420 | +108% |
| Gross operating margin | 9900 | €180,343 | €178,752 | -€1,591 | -0.9% |
| Operating profit (loss) | 9901 | €178,092 | €175,617 | -€2,475 | -1.4% |
| Financial income | 75/76B | €0 | €0 | +€0 | +1,900% |
| Recurring financial income | 75 | €0 | €0 | +€0 | +1,900% |
| Financial charges | 65/66B | €31 | €70 | +€39 | +126% |
| Recurring financial charges | 65 | €31 | €70 | +€39 | +126% |
| Profit (loss) for the period before taxes | 9903 | €178,061 | €175,548 | -€2,514 | -1.4% |
| Income taxes | 67/77 | €41,589 | €46,300 | +€4,711 | +11.3% |
| Profit (loss) for the period | 9904 | €136,472 | €129,248 | -€7,225 | -5.3% |
| Profit (loss) for the period to be appropriated | 9905 | €136,472 | €129,248 | -€7,225 | -5.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.